Drug class
Inhaled/intranasal glucocorticoid; corticosteroid prodrug
Mechanism of action
Ciclesonide is converted by esterases in airway and nasal tissues to the active metabolite des-ciclesonide, which binds glucocorticoid receptors and suppresses inflammatory gene expression and mediator release.
General use cases
- Maintenance treatment of asthma with inhaled formulations; not intended for relief of acute bronchospasm
- Treatment or prevention of symptoms of seasonal and perennial allergic rhinitis with authorised intranasal formulations; age eligibility is product- and jurisdiction-specific
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
